McKesson Is Roped Into Generic-Drug Price-Fixing Row
McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first...To view the full article, register now.
Already a subscriber? Click here to view full article